Wednesday, June 1, 2016

BRIEF-Alexion Pharmaceuticals says EC grants orphan drug designation to ALXN1210

* European Commission has granted orphan drug designation to

ALXN1210

Source text for Eikon:

Further company coverage:

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)